SL Science Holding Limited Ordinary Shares (NASDAQ:SLBT) — Market Cap & Net Worth
Market Cap & Net Worth: SL Science Holding Limited Ordinary Shares (SLBT)
SL Science Holding Limited Ordinary Shares (NASDAQ:SLBT) has a market capitalization of $1.48 Billion ($1.48 Billion) as of August 28, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7336 globally and #2235 in its home market, demonstrating a -1.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SL Science Holding Limited Ordinary Shares's stock price $2.64 by its total outstanding shares 560759757 (560.76 Million). Check SL Science Holding Limited Ordinary Shar share price for real-time trading data and today's change.
SL Science Holding Limited Ordinary Shares Market Cap History: 2026 to 2026
SL Science Holding Limited Ordinary Shares's market capitalization history from 2026 to 2026. Data shows growth from $1.48 Billion to $1.48 Billion (0.00% CAGR).
SL Science Holding Limited Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SL Science Holding Limited Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SLBT net assets to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLBT by Market Capitalization
Companies near SL Science Holding Limited Ordinary Shares in the global market cap rankings as of August 28, 2026. Also see SLBT cash generation efficiency for how efficiently the company converts equity into cash flow.
Key companies related to SL Science Holding Limited Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #335 globally with a market cap of $81.69 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $59.69 Billion USD ( AU$84.36 Billion AUD).
- Samsung Biologics Co Ltd (KO:207940): Ranked #556 globally with a market cap of $50.00 Billion USD ( ₩73.79 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.55 |
| #335 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $81.69 Billion | $807.71 |
| #459 | CSL Ltd | AU:CSL | $59.69 Billion | AU$173.88 |
| #556 | Samsung Biologics Co Ltd | KO:207940 | $50.00 Billion | ₩1594000.00 |
SL Science Holding Limited Ordinary Shares Historical Marketcap From 2026 to 2026
Between 2026 and today, SL Science Holding Limited Ordinary Shares's market cap moved from $1.48 Billion to $ 1.48 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.48 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 28th, 2026 the market cap of SL Science Holding Limited Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.48 Billion USD |
| MoneyControl | $1.48 Billion USD |
| MarketWatch | $1.48 Billion USD |
| marketcap.company | $1.48 Billion USD |
| Reuters | $1.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was for… Read more